1
|
Characterization of the human cysteinyl leukotriene 2 receptor.
|
J Biol Chem
|
2000
|
2.89
|
2
|
Identification of receptors for neuromedin U and its role in feeding.
|
Nature
|
2000
|
1.60
|
3
|
Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception.
|
J Biol Chem
|
2001
|
1.20
|
4
|
Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells.
|
Cancer Chemother Pharmacol
|
1997
|
0.85
|
5
|
UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells.
|
Int J Oncol
|
2000
|
0.82
|
6
|
Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G(2) arrest.
|
Cancer Chemother Pharmacol
|
2000
|
0.81
|
7
|
Polymerase chain reaction analysis of cisplatin-induced mitochondrial DNA damage in human ovarian carcinoma cells.
|
Anticancer Drugs
|
1995
|
0.76
|
8
|
Against time-limited certification.
|
J Am Acad Dermatol
|
1989
|
0.76
|
9
|
Cloning and expression of bovine p47-phox and p67-phox: comparison with the human and murine homologs.
|
J Leukoc Biol
|
2000
|
0.75
|
10
|
Cloning and characterization of bovine low molecular weight GTPases (Rac1 and Rac2) and rho GDP-dissociation inhibitor 2 (D4-GDI).
|
Vet Immunol Immunopathol
|
2000
|
0.75
|
11
|
Direct immunofluorescence in bullous pemphigoid: effects of extent and location of lesions.
|
J Am Acad Dermatol
|
1989
|
0.75
|